BPC-157 5mg + TB-500 5mg (Blend)
BPC-157 5mg + TB-500 5mg
$120.00
Research Information
| Better alternatives context | The 10mg+10mg version lasts twice as long per vial. GLOW/KLOW blends add GHK-Cu (and KPV) but at lower BPC/TB doses per unit — better as a complement, not replacement. |
| Better alternatives context rt |
{"type"=>"root", "children"=>[{"type"=>"paragraph", "children"=>[{"type"=>"text", "value"=>"The 10mg+10mg version lasts twice as long per vial. GLOW/KLOW blends add GHK-Cu (and KPV) but at lower BPC/TB doses per unit — better as a complement, not replacement."}]}]}
|
| Body vs external supply | 🟡 Natural/Topping Up |
| Brand trade names |
No pharmaceutical brand Compounding pharmacy blend |
| Brand trade names rt |
{"type"=>"root", "children"=>[{"type"=>"paragraph", "children"=>[{"type"=>"text", "value"=>"No pharmaceutical brand"}]}, {"type"=>"paragraph", "children"=>[{"type"=>"text", "value"=>"Compounding pharmacy blend"}]}]}
|
| Common side effects | Combined: headache, flushing, mild GI. Generally well-tolerated. |
| Common side effects rt |
{"type"=>"root", "children"=>[{"type"=>"paragraph", "children"=>[{"type"=>"text", "value"=>"Combined: headache, flushing, mild GI. Generally well-tolerated."}]}]}
|
| Contraindications do not combine |
• Avoid NSAIDs during use • Avoid if active cancer/tumour history (angiogenesis concern) |
| Contraindications do not combine rt |
{"type"=>"root", "children"=>[{"type"=>"list", "listType"=>"unordered", "children"=>[{"type"=>"list-item", "children"=>[{"type"=>"text", "value"=>"Avoid NSAIDs during use"}]}, {"type"=>"list-item", "children"=>[{"type"=>"text", "value"=>"Avoid if active cancer/tumour history (angiogenesis concern)"}]}]}]}
|
| Delivery method | SubQ injection |
| Drug interactions | Unknown |
| Endogenous | Natural/Topping Up |
| Fda status | Category 2 (2023) |
| Full effect days | 42 |
| Half life | ~4h / ~4-6h |
| Half life detail | BPC: ~4hrs | TB-500: ~4-6hrs |
| Half life hours | 5.0 |
| Key studies references |
• No published studies on this specific combination • Based on individual component research (see BPC-157 and TB-500 entries) • NOT FDA APPROVED |
| Key studies references rt |
{"type"=>"root", "children"=>[{"type"=>"list", "listType"=>"unordered", "children"=>[{"type"=>"list-item", "children"=>[{"type"=>"text", "value"=>"No published studies on this specific combination"}]}, {"type"=>"list-item", "children"=>[{"type"=>"text", "value"=>"Based on individual component research (see BPC-157 and TB-500 entries)"}]}, {"type"=>"list-item", "children"=>[{"type"=>"text", "value"=>"NOT FDA APPROVED"}]}]}]}
|
| Known for |
{"type"=>"root", "children"=>[{"type"=>"paragraph", "children"=>[{"type"=>"text", "value"=>"The standard healing stack pre-blended. Combines localised tissue repair (BPC) with systemic healing and cell migration (TB-500). Ideal for injury recovery, joint health, and faster return to training."}]}]}
|
| Mechanism of action simplified | Combined healing stack — BPC-157 (local, gut, tendon) + TB-500 (systemic, cardiac, anti-inflammatory). Complementary mechanisms. |
| Mechanism of action simplified rt |
{"type"=>"root", "children"=>[{"type"=>"paragraph", "children"=>[{"type"=>"text", "value"=>"Combined healing stack — BPC-157 (local, gut, tendon) + TB-500 (systemic, cardiac, anti-inflammatory). Complementary mechanisms."}]}]}
|
| Onset days | 5 |
| Recommended vial size |
★ 5mg+5mg per vial At 10 units/day (2ml BAC) = ~10 days ✓. No shelf life issues. |
| Recommended vial size rt |
{"type"=>"root", "children"=>[{"type"=>"list", "listType"=>"unordered", "children"=>[{"type"=>"list-item", "children"=>[{"type"=>"text", "value"=>"5mg+5mg per vial"}]}]}, {"type"=>"paragraph", "children"=>[{"type"=>"text", "value"=>"At 10 units/day (2ml BAC) = ~10 days ✓. No shelf life issues."}]}]}
|
| Reversibility | Fully reversible |
| Shelf life reconstituted | 4–6 weeks |
| Storage lyophilised | 2–8°C |
| Storage requirements | Reconstituted: 2-8°C, 14-21 days |
| Subtitle | Peptide blend · BPC-157 + Thymosin Beta-4 · Synthetic |
| Suppression | None |
| Time to effects |
EARLY: 3-7 days FULL: 4-8 weeks Combines the fast onset of BPC-157 with the systemic healing of TB-500. Day 3-7: Pain reduction and inflammation improvements (BPC effect). Week 1-2: Healing acceleration noticeable. Week 4-8: Major injury recovery. Flexibility improvements. Minimum commitment: 4 weeks. |
| Time to effects rt |
{"type"=>"root", "children"=>[{"type"=>"paragraph", "children"=>[{"type"=>"text", "value"=>"EARLY: ", "bold"=>true}, {"type"=>"text", "value"=>"3-7 days"}]}, {"type"=>"paragraph", "children"=>[{"type"=>"text", "value"=>"FULL: ", "bold"=>true}, {"type"=>"text", "value"=>"4-8 weeks"}]}, {"type"=>"paragraph", "children"=>[{"type"=>"text", "value"=>"Combines the fast onset of BPC-157 with the systemic healing of TB-500."}]}, {"type"=>"paragraph", "children"=>[{"type"=>"text", "value"=>"Day 3-7: Pain reduction and inflammation improvements (BPC effect)."}]}, {"type"=>"paragraph", "children"=>[{"type"=>"text", "value"=>"Week 1-2: Healing acceleration noticeable."}]}, {"type"=>"paragraph", "children"=>[{"type"=>"text", "value"=>"Week 4-8: Major injury recovery. Flexibility improvements."}]}, {"type"=>"paragraph", "children"=>[{"type"=>"text", "value"=>"Minimum commitment: 4 weeks."}]}]}
|
| Typical dosage | 5-10 units daily with 2ml BAC water (250-500mcg of each per dose). SubQ near injury or abdominally. |
| Typical dosage rt |
{"type"=>"root", "children"=>[{"type"=>"paragraph", "children"=>[{"type"=>"text", "value"=>"5-10 units daily with 2ml BAC water (250-500mcg of each per dose). SubQ near injury or abdominally."}]}]}
|
| Typical dose short | 250-500mcg |
| Vial duration | At 10 units/day = ~10 days per vial. |
| Video references | https://www.youtube.com/watch?v=HIrI8STJPJo, https://www.youtube.com/watch?v=gaQwrB8HW4o, https://www.youtube.com/watch?v=cNNuh2dLpDQ |
| Wada status | Prohibited (S0) |